Invenra

Invenra

Invenra

Invenra is focused on developing the next generation of bestinclass biologics, with an emphasis on multispecific antibodies and their derivatives.
Founded
2011
Raised
$16.1M
Follow us
Alexa global traffic share
Latest funding Show all
$2,930,060
Venture capital - 2017
$2,000,000
Venture capital - 2016
Team Size
10+
Employees
$2,930,060 Venture capital
Xconomy

Invenra, Developer of Therapeutic Antibodies, Raises $2.9M

Health Funding
Xconomy

Invenra Signs On With Merck in Antibody Discovery Partnership

Health Apps & Services
Xconomy

Invenra Adds Partners, Still Open to Developing Own Drugs in Future

Science Health
$3,000,000 Venture capital
Xconomy

Invenra Raises $3M to Develop Antibodies with, and for, Drug Makers

Funding
$2,000,000 Venture capital
SmartBrief

Financing round brings in $2M for Invenra

$2,000,000 Venture capital
Xconomy

Invenra Snags $2M, Expects to Raise $1M More in Next Month

Funding Health
Xconomy

Invenra Partners With U.K. Company to Research Therapeutic Antibodies

Health Science Apps & Services